HAVCR1 and Cirrhosis: Patients with cirrhosis, decompensation, and organ failure (so called acute-on-chronic liver failure, ACLF) portray disease-characterising immune dysregulation that, along with complications like hepatorenal syndrome, may present stimuli for higher KIM-1 release.